Osteoporosis, Arthritis and Musculoskeletal Disorders

Management of Osteoporosis in the Era of COVID-19

Osteoporosis is a chronic illness characterised by weakened bones and an increased risk of fracture. Osteoporosis is a chronic disorder that usually need long-term medical treatment to prevent further bone loss, skeletal integrity damage, and fractures. The fact that rapid termination of some medications is linked to an elevated risk of injury further complicates the situation. In this setting, the COVID-19 pandemic has caused extraordinary disruption in the delivery of health care throughout the world, including near-universal social distancing restrictions. In this Perspective, we present information on the general management of osteoporosis patients in the COVID-19 period, when available, and clinical recommendations based mostly on expert opinion when data are lacking. The transition from parenteral osteoporosis treatments is given special attention. These suggestions are envisaged to be used to safely guide care for osteoporosis patients until a restoration to normal clinical care standards is possible.